← Back to screener

Concentrix Corp CNXC

Rank #141 · Nasdaq · $1.8B market cap
Audited by Ernst & Young LLP, no going-concern flag in the latest filing.
Score
75.5
P/E
5.9
P/B
0.68
ROE
11.6%
Op. Margin
9.3%
Debt Ratio
295%

Health Check — percentile rank within this universe, based on the latest annual filing

Valuation ★★★★★
Excellent

P/E 5.9x, P/B 0.68x. Ranks in the top 5% of the universe.

Profitability ★★★☆☆
Average

ROE 11.6%. Ranks in the top 42% of the universe.

Safety ★☆☆☆☆
Weak

Debt ratio 295%. Ranks in the top 71% of the universe. Above 200% signals meaningful leverage risk.

Growth ★★★★☆
Good

Revenue growth of 12.5% year over year. Ranks in the top 29% of the universe.

Valuation is the relative strength · Safety is the relative weakness (relative to this universe).

Financials annual, from SEC 10-K filings

FYRevenueOp. IncomeNet IncomeEquityOp. Margin%Debt%
2021$4.7B$0.3B$0.1B$1.3B6.3218
2022$4.7B$0.3B$0.2B$1.5B6.5165
2023$5.6B$0.6B$0.4B$2.3B10.2173
2024$6.3B$0.6B$0.4B$2.6B10.1319
2025$7.1B$0.7B$0.3B$2.7B9.3295

← See the full screener